Lantheus to Share Insights at the Upcoming MedTech Conference
Lantheus to Present at the MedTech Conference
In Bedford, Massachusetts, Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in radiopharmaceuticals, has exciting news to share. The Chief Executive Officer, Brian Markison, is scheduled to present at the 2025 Truist Securities MedTech Conference, making waves in the healthcare industry.
Event Details
The presentation is set for 8:40 a.m. ET on a Tuesday in June. This conference serves as a notable gathering where innovative minds meet to discuss the future of medical technology and treatments. Lantheus aims to highlight its role in improving patient outcomes through advanced radiopharmaceutical solutions.
How to Tune In
For those interested in following the presentation live, Lantheus has made it easy. The Investors section of their official website will host a live webcast of the event. This gives all stakeholders a chance to gain insights into the company’s future direction and the evolving landscape of healthcare technology.
A Replay Available for Access
After the live event, a replay will also be made available on the company’s website for at least 30 days. This ensures that anyone unable to attend the live presentation can still benefit from the valuable information shared during the event.
About Lantheus
Lantheus stands at the forefront of radiopharmaceutical innovation, specializing in solutions that allow clinicians to Find, Fight, and Follow disease effectively. With a legacy of nearly 70 years, Lantheus has been dedicated to advancing healthcare through science. Although headquartered in Massachusetts, their influence extends globally, with offices in New Jersey, Canada, Sweden, and Switzerland, showcasing their commitment to worldwide health.
Contact Information
Should you have any inquiries or require further information, Lantheus offers direct contacts:
Investor Relations
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
External Communications
Melissa Downs
Executive Director, External Communications
646-975-2533
media@lantheus.com
Frequently Asked Questions
What will Lantheus discuss at the conference?
Lantheus will present its advancements in radiopharmaceuticals and their impact on patient outcomes.
When is the MedTech Conference?
The presentation will take place at 8:40 a.m. ET on a Tuesday in June.
How can I listen to the presentation?
A live webcast will be available on Lantheus' Investors section on their website.
Will there be a replay of the presentation?
Yes, a replay will be accessible on their website for at least 30 days.
How long has Lantheus been in business?
Lantheus has been providing radiopharmaceutical solutions for nearly 70 years, making a significant impact in healthcare.
About The Author
Contact Dominic Sanders privately here. Or send an email with ATTN: Dominic Sanders as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.